The Global Health Body Raises Alert Over Severe Lack of Obesity Jabs

Under a tenth of individuals eligible to benefit from GLP-1 drugs such as Wegovy have access to them, caution the global health agency as it issues its inaugural advice on the medications.

Considering over a billion people worldwide currently living with obesity, it is advocating for increased and just availability to these injectable treatments.

Per estimates, in excess of 2,000,000,000 will be obese by 2030 unless action is taken.

"Our new guidelines acknowledges that obesity is a chronic disease that can be treated with holistic and continuous support," remarked the agency's head Tedros Adhanom Ghebreyesus.

Substantial prices, limited production capacity, and distribution challenges are significant barriers to broad access to the injections that can help people shift substantial body mass, says the body.

Skinny Jab Scarcity

Despite the present most favorable scenario, the manufacturing of such drugs would only suffice for approximately 100 million people – under 10% of those who need them, per the health organization.

The guideline encourages nations and manufacturers to increase availability, by strategies such as patent sharing.

Exclusive production rights on the active ingredient – the core ingredient of the drug Wegovy – is set to lapse in several countries in 2026.

How Weight-Loss Injections Work

The injections mimick a natural hormone to reduce digestion speed, curb appetite and boost feelings of fullness so users consume fewer calories.

People usually begin shedding pounds after several weeks of starting on the weekly injections.

Studies indicates patients may put most of the weight back on a year later of stopping the medication, as their typical food cravings come back.

Being overweight or obese raises your likelihood for developing medical conditions, such as type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity affects individuals in all nations and was responsible for over three and a half million deaths worldwide in 2024, per the health agency.

David Whitney
David Whitney

Lars van den Berg is een ervaren consultant met expertise in bedrijfsstrategie en procesoptimalisatie.